Kheiron scores $22 mln Series A
Kheiron Medical Technologies, an applied science company focused on supporting cancer diagnostics with machine learning, has raised $22 million in Series A funding. Atomico led the round with participation from Connect Ventures, Greycroft, Hoxton Ventures and EXOR Seeds. As part of this investment, Atomico Principal Irina Haivas will join Kheiron's board.
24 September 2019•1 min read
